Dr. Mindel received his B.A. at Swarthmore College and his M.D. from the University of Maryland. He did his internship and residency at the University of Michigan, where he returned to achieve his M.S. in Ophthalmology after completing a fellowship in Neuro-Ophthalmology at Columbia-Presbyterian Hospital. Dr. Mindel completed a second fellowship in Ocular-Pharmacology at the Mount Sinai School of Medicine, where he then received his Ph.D. in Pharmacology. He is a Diplomate of the American Board of Ophthalmology.
A member of both the American Academy of Ophthalmology and the Americal Ophthalmological Society, Dr. Mindel serves as a consultant to the FDA Dermatologic and Ophthalmic Drugs Advisory Committee and as a delegate from both Mount Sinai and the American Academy of Ophthalmology to the US Pharmacopeial Convention. Dr. Mindel serves on the Editorial Board and Editorial Advisory Board for Ophthalmology, and has for the past 20 years been co-editor of the Ocular Pharmacology Section of Duane's Biomedical Foundations of Ophthalmology. Now in his 15th year, he continues as Co-editor of Therapeutic Reviews for Survey of Ophthalmology.
MD, University of Maryland
University of Michigan Hospitals
University of Michigan Hospitals
Columbia-Presbyterian Medical Center
Fellowship, Occular Pharmacology
Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Mindel did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.